These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18370851)

  • 1. Taiwan Biobank: a project aiming to aid Taiwan's transition into a biomedical island.
    Fan CT; Lin JC; Lee CH
    Pharmacogenomics; 2008 Feb; 9(2):235-46. PubMed ID: 18370851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of development of population-based study in the biomedical field on laws and regulations: a cross-strait experience on biobank development.
    Te FC; Chunyan W; Zhiyuan S
    J Int Bioethique; 2012 Jun; 23(2):143-63, 181-3. PubMed ID: 22924199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taiwan Regulation of Biobanks.
    Fan CT; Hung TH; Yeh CK
    J Law Med Ethics; 2015; 43(4):816-26. PubMed ID: 26711420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of development of population-based study in biomedical field on laws and regulations: a cross-strait experience on biobank development.
    Fan CT; Wu C; Shi Z
    J Int Bioethique; 2008 Dec; 19(4):117-37, 166. PubMed ID: 19492726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Start-up of a clinical sample processing, storage and management platform: organisation and development of the REDinREN Biobank.
    Calleros L; Cortés MA; Luengo A; Mora I; Guijarro B; Martín P; Ortiz-Arduán A; Selgas R; Rodríguez-Puyol D; Rodríguez-Puyol M
    Nefrologia; 2012; 32(1):28-34. PubMed ID: 22294002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case of biobank with the law: between a legal and scientific fiction.
    Sándor J; Bárd P; Tamburrini C; Tännsjö T
    J Med Ethics; 2012 Jun; 38(6):347-50. PubMed ID: 21947810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.
    Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A
    Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing "incidental findings" in biobank research: Recommendations of the Taiwan biobank.
    Lin JC; Hsiao WW; Fan CT
    Comput Struct Biotechnol J; 2019; 17():1135-1142. PubMed ID: 31462969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].
    Boeckhout M; van Dijk J; Legemate DA
    Ned Tijdschr Geneeskd; 2011; 155(26):A3557. PubMed ID: 21767425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taiwan Biobank: making cross-database convergence possible in the Big Data era.
    Lin JC; Fan CT; Liao CC; Chen YS
    Gigascience; 2018 Jan; 7(1):1-4. PubMed ID: 29149267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic data sample collection and storage: ethical issues and policy approaches.
    Joly Y; Knoppers BM
    Pharmacogenomics; 2006 Mar; 7(2):219-26. PubMed ID: 16515401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.
    Lin JC; Hsiao WW; Fan CT
    J Transl Med; 2020 Aug; 18(1):304. PubMed ID: 32762757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partnership in U.K. Biobank: a third way for genomic property?
    Winickoff DE
    J Law Med Ethics; 2007; 35(3):440-56. PubMed ID: 17714253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample, data use and protection in biobanking in Europe: legal issues.
    Zika E; Schulte In den Bäumen T; Kaye J; Brand A; Ibarreta D
    Pharmacogenomics; 2008 Jun; 9(6):773-81. PubMed ID: 18518854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Governance and measures for the ethical and social aspects of biobanks].
    Iwae S; Masui T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):493-7. PubMed ID: 22504670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.